{"id":46275,"date":"2025-11-17T14:39:44","date_gmt":"2025-11-17T12:39:44","guid":{"rendered":"https:\/\/www.incliva.es\/services\/researcher-services\/scientific-management\/innovation-support-unit\/oferta-tecnologica-spin-offs\/"},"modified":"2026-03-25T15:21:29","modified_gmt":"2026-03-25T13:21:29","slug":"oferta-tecnologica-spin-offs","status":"publish","type":"page","link":"https:\/\/www.incliva.es\/en\/services\/researcher-services\/scientific-management\/innovation-support-unit\/oferta-tecnologica-spin-offs\/","title":{"rendered":"Oferta tecnol\u00f3gica \/ Spin-offs"},"content":{"rendered":"<p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#e2e2e2;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><div class=\"fusion-text fusion-text-1\" style=\"transform:translate3d(0,0,0);\"><h5>Technological Offer<\/h5>\n<p>Since its formal constitution as a Biomedical Reseach Institute in 2010, INCLIVA has achieved notable achievements because of its research activity. It is worth highlighting the more than 20 patents and 4 registered software programmes, as well as 4 spin-off companies that have been created because of research carried out within INCLIVA.<\/p>\n<\/div><style type=\"text\/css\">.fusion-accordian  #accordion-46275-1 .panel-title a .fa-fusion-box{ color: #ffffff;}.fusion-accordian  #accordion-46275-1 .panel-title a .fa-fusion-box:before{ font-size: 14px; width: 14px;}.fusion-accordian  #accordion-46275-1.fusion-toggle-icon-right .fusion-toggle-heading{ margin-right: 32px;}.fusion-accordian  #accordion-46275-1 .panel-title a{font-size:14px;}.fusion-accordian  #accordion-46275-1 .fa-fusion-box { background-color: #212934;border-color: #212934;}.fusion-accordian  #accordion-46275-1 .panel-title a:hover, #accordion-46275-1 .fusion-toggle-boxed-mode:hover .panel-title a { color: #3d44ac;}.fusion-accordian  #accordion-46275-1 .panel-title .active .fa-fusion-box,.fusion-accordian  #accordion-46275-1 .panel-title a:hover .fa-fusion-box { background-color: #3d44ac!important;border-color: #3d44ac!important;}<\/style><div class=\"accordian fusion-accordian\"><div class=\"panel-group fusion-toggle-icon-right\" id=\"accordion-46275-1\" role=\"tablist\"><div class=\"fusion-panel panel-default\" role=\"tabpanel\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\"><a class=\"active\" aria-expanded=\"true\" aria-selected=\"true\" aria-controls=\"4f5bc88639892583e\" role=\"tab\" data-toggle=\"collapse\" data-parent=\"#accordion-46275-1\" data-target=\"#4f5bc88639892583e\" href=\"#4f5bc88639892583e\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Results<\/span><\/a><\/h4><\/div><div id=\"4f5bc88639892583e\" class=\"panel-collapse collapse in\"><div class=\"panel-body toggle-content fusion-clearfix\"><div class=\"fusion-builder-row fusion-builder-row-inner fusion-row fusion-flex-align-items-flex-start\" style=\"width:104% !important;max-width:104% !important;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-0 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-2\" style=\"transform:translate3d(0,0,0);\"><p><strong>OPTIMIZATION DEVICE FOR INTRAURETHRAL LUBRICATION IN PEDIATRIC PATIENTS<\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-3\" style=\"transform:translate3d(0,0,0);\"><p><strong>Grupo:<\/strong> Urolog\u00eda<\/p>\n<\/div><div class=\"fusion-text fusion-text-4\" style=\"transform:translate3d(0,0,0);\"><p><strong>Tipo:<\/strong> Modelo de utilidad<\/p>\n<\/div><div class=\"fusion-text fusion-text-5\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/03\/Oferta-tecnologica_en_i2021_10.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-0{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-0 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-0{width:50% !important;order : 0;}.fusion-builder-nested-column-0 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-0{width:100% !important;order : 0;}.fusion-builder-nested-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-1 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-6\" style=\"transform:translate3d(0,0,0);\"><p><strong>Novel treatment with PPAR modulators for metabolic diseases<\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-7\" style=\"transform:translate3d(0,0,0);\"><p><strong>Grupo: <\/strong>Qu\u00edmica M\u00e9dica<\/p>\n<\/div><div class=\"fusion-text fusion-text-8\" style=\"transform:translate3d(0,0,0);\"><p><strong>Tipo:<\/strong> Patente<\/p>\n<\/div><div class=\"fusion-text fusion-text-9\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/03\/Oferta-Tecnologica_EN_i2024_02.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-1{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-1 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-1{width:50% !important;order : 0;}.fusion-builder-nested-column-1 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-1{width:100% !important;order : 0;}.fusion-builder-nested-column-1 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-2 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-10\" style=\"transform:translate3d(0,0,0);\"><p><strong>OROPHARYNGEAL OBTURATION DEVICE (OROTAPNN)<\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-11\" style=\"transform:translate3d(0,0,0);\"><p><strong>Grupo:<\/strong> Cirug\u00eda maxiolofacial<\/p>\n<\/div><div class=\"fusion-text fusion-text-12\" style=\"transform:translate3d(0,0,0);\"><p><strong>Tipo:<\/strong> Patente<\/p>\n<\/div><div class=\"fusion-text fusion-text-13\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/03\/Oferta-tecnologica_en_i2018-15.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-video fusion-selfhosted-video\" style=\"max-width:100%;\"><div class=\"video-wrapper\"><video playsinline=\"true\" width=\"100%\" style=\"object-fit: cover;\" loop=\"true\" preload=\"auto\" controls=\"1\"><source src=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/documentacion\/innovacion\/oferta_tecnologica\/MAXILOFACIAL%202021.mp4\" type=\"video\/mp4\">Sorry, your browser doesn&#039;t support embedded videos.<\/video><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-2{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-2 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-2{width:50% !important;order : 0;}.fusion-builder-nested-column-2 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-2{width:100% !important;order : 0;}.fusion-builder-nested-column-2 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-3 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-14\" style=\"transform:translate3d(0,0,0);\"><p><strong>Moxifloxacino para uso en el tratamiento de la atrofia muscular espinal<\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-15\" style=\"transform:translate3d(0,0,0);\"><p><strong>Grupo:<\/strong> Gen\u00f3mica Traslacional Humana<\/p>\n<\/div><div class=\"fusion-text fusion-text-16\" style=\"transform:translate3d(0,0,0);\"><p><strong>Tipo:<\/strong> Patente<\/p>\n<\/div><div class=\"fusion-text fusion-text-17\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/documentacion\/innovacion\/oferta_tecnologica\/Moxifloxacino_Oferta%20tecno_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:46px;width:100%;\"><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-3{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-3 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-3{width:50% !important;order : 0;}.fusion-builder-nested-column-3 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-3{width:100% !important;order : 0;}.fusion-builder-nested-column-3 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-4 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-18\" style=\"transform:translate3d(0,0,0);\"><p><strong>Cathlab Sim: SOFTWARE FOR THE SIMULATION OF PERCUTANEOUS CARDIAC INTERVENTIONS AND THE TRAINING OF HEALTHCARE STAFF<\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-19\" style=\"transform:translate3d(0,0,0);\"><p><strong>Grupo:<\/strong> Cardiolog\u00eda Cl\u00ednica<\/p>\n<\/div><div class=\"fusion-text fusion-text-20\" style=\"transform:translate3d(0,0,0);\"><p><strong>Tipo:<\/strong> Software<\/p>\n<\/div><div class=\"fusion-text fusion-text-21\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/03\/Oferta-tecnologica_en_i2020-13.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-4{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-4 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-4{width:50% !important;order : 0;}.fusion-builder-nested-column-4 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-4{width:100% !important;order : 0;}.fusion-builder-nested-column-4 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-5 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-22\" style=\"transform:translate3d(0,0,0);\"><p><strong>ReMindCare: una plataforma para la evaluaci\u00f3n del estado cl\u00ednico del paciente y la comunicaci\u00f3n entre paciente y m\u00e9dico en psiquiatr\u00eda<\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-23\" style=\"transform:translate3d(0,0,0);\"><p><strong>Grupo:<\/strong> Psiquiatr\u00eda y Enfermedades Neurodegenerativas<\/p>\n<\/div><div class=\"fusion-text fusion-text-24\" style=\"transform:translate3d(0,0,0);\"><p><strong>Tipo:<\/strong> Software<\/p>\n<p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/09\/Oferta-tecnologica_es_2018-41-Software-Remindcare_Sanjuan.pdf\" target=\"_blank\" rel=\"noopener\">Descripci\u00f3n<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-5{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-5 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-5{width:50% !important;order : 0;}.fusion-builder-nested-column-5 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-5{width:100% !important;order : 0;}.fusion-builder-nested-column-5 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-6 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-25\" style=\"transform:translate3d(0,0,0);\"><p><strong>M\u00e9todo de evaluaci\u00f3n de la actividad de la nicotinamida <em>N<\/em>-metil transferasa. Metabotest<\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-26\" style=\"transform:translate3d(0,0,0);\"><p><strong>Grupo:<\/strong> C\u00e1ncer colorrectal y nuevos desarrollos terap\u00e9uticos en tumores s\u00f3lidos<\/p>\n<\/div><div class=\"fusion-text fusion-text-27\" style=\"transform:translate3d(0,0,0);\"><p><strong>Tipo:<\/strong> Patente<\/p>\n<\/div><div class=\"fusion-text fusion-text-28\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2024\/08\/Oferta-tecnologica_es_2020-19.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-6{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-6 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-6{width:50% !important;order : 0;}.fusion-builder-nested-column-6 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-6{width:100% !important;order : 0;}.fusion-builder-nested-column-6 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-7 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-29\" style=\"transform:translate3d(0,0,0);\"><p><strong>MOLECULAR TOOLS FOR THE DIAGNOSIS AND PROGNOSIS OF SPITZOID MELANOCYTIC TUMOURS <\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-30\" style=\"transform:translate3d(0,0,0);\"><p><strong>Grupo: <\/strong>C\u00e1ncer Cut\u00e1neo<\/p>\n<\/div><div class=\"fusion-text fusion-text-31\" style=\"transform:translate3d(0,0,0);\"><p><strong>Tipo:<\/strong> Patente<\/p>\n<\/div><div class=\"fusion-text fusion-text-32\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/03\/Oferta-tecnologica_en_2019-35.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-7{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-7 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-7{width:50% !important;order : 0;}.fusion-builder-nested-column-7 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-7{width:100% !important;order : 0;}.fusion-builder-nested-column-7 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-8 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-33\" style=\"transform:translate3d(0,0,0);\"><p><strong>Haloperidol para el tratamiento de la atrofia muscular espinal<\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-34\" style=\"transform:translate3d(0,0,0);\"><p><strong>Grupo:<\/strong> Gen\u00f3mica Traslacional Humana<\/p>\n<\/div><div class=\"fusion-text fusion-text-35\" style=\"transform:translate3d(0,0,0);\"><p><strong>Tipo:<\/strong> Patente<\/p>\n<\/div><div class=\"fusion-text fusion-text-36\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2024\/08\/Oferta-tecnologica_es_2024-1.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-8{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-8 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-8{width:50% !important;order : 0;}.fusion-builder-nested-column-8 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-8{width:100% !important;order : 0;}.fusion-builder-nested-column-8 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-9 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-37\" style=\"transform:translate3d(0,0,0);\"><p><strong>Material inyectable para la regeneraci\u00f3n del cart\u00edlago articular<\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-38\" style=\"transform:translate3d(0,0,0);\"><p><strong>Grupo:<\/strong> Histopatolog\u00eda e Ingenier\u00eda Tisular<\/p>\n<\/div><div class=\"fusion-text fusion-text-39\" style=\"transform:translate3d(0,0,0);\"><p><strong>Tipo:<\/strong> Patente<\/p>\n<\/div><div class=\"fusion-text fusion-text-40\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2024\/08\/Oferta-tecnologica_es_2018-14.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div>\n<div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-9{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-9 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-9{width:50% !important;order : 0;}.fusion-builder-nested-column-9 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-9{width:100% !important;order : 0;}.fusion-builder-nested-column-9 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-10 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-41\" style=\"transform:translate3d(0,0,0);\"><p><strong>AMMON-OHE: A Machine Learning Model to Predict Occurrence of Overt Hepatic Encephalopathy in Patients with Cirrhosis <\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-42\" style=\"transform:translate3d(0,0,0);\"><p><strong>Grupo:<\/strong> Research Group on Neurological Impairment<\/p>\n<\/div><div class=\"fusion-text fusion-text-43\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type:<\/strong> Patent<\/p>\n<\/div><div class=\"fusion-text fusion-text-44\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/04\/i2023_05_Technological-offer_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-10{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-10 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-10{width:50% !important;order : 0;}.fusion-builder-nested-column-10 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-10{width:100% !important;order : 0;}.fusion-builder-nested-column-10 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-11 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-45\" style=\"transform:translate3d(0,0,0);\"><p><strong>Device for blood cannulation for haemodialysis<\/strong><\/p>\n<div class=\"fusion-text fusion-text-45\" style=\"transform:translate3d(0,0,0);\"><\/div>\n<p><strong>Group:<\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-47\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type:<\/strong> Patent<\/p>\n<\/div><div class=\"fusion-text fusion-text-48\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/04\/Tecnological-offer_i2024-35_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div>\n<div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-11{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-11 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-11{width:50% !important;order : 0;}.fusion-builder-nested-column-11 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-11{width:100% !important;order : 0;}.fusion-builder-nested-column-11 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-12 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-49\" style=\"transform:translate3d(0,0,0);\"><p><strong>SepAsT: Software for early sepsis diagnosis of sepsis and patients clinical clourse and septic shock<\/strong><\/p>\n<div class=\"fusion-text fusion-text-49\" style=\"transform:translate3d(0,0,0);\"><\/div>\n<p><strong>Group:<\/strong> Research Group on Epigenomics and Translational Epigenetics<\/p>\n<\/div><div class=\"fusion-text fusion-text-51\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type:<\/strong> Software<\/p>\n<\/div><div class=\"fusion-text fusion-text-52\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/04\/Oferta-tecnologica__i2024_33_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-12{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-12 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-12{width:50% !important;order : 0;}.fusion-builder-nested-column-12 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-12{width:100% !important;order : 0;}.fusion-builder-nested-column-12 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-13 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-53\" style=\"transform:translate3d(0,0,0);\"><p><strong>Musashi 2 (MSI2) como diana terap\u00e9utica para el tratamiento de la distrofia miot\u00f3nica tipo 1 y 2<\/strong><\/p>\n<div class=\"fusion-text fusion-text-53\" style=\"transform:translate3d(0,0,0);\"><\/div>\n<p><strong>Group:<\/strong> Research Group on Human Translational Genomics<\/p>\n<\/div><div class=\"fusion-text fusion-text-55\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type:<\/strong> Patent<\/p>\n<\/div><div class=\"fusion-text fusion-text-56\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2026\/03\/i2019_16_Technological-offer_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-13{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-13 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-13{width:50% !important;order : 0;}.fusion-builder-nested-column-13 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-13{width:100% !important;order : 0;}.fusion-builder-nested-column-13 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-14 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\">\n<div class=\"fusion-text fusion-text-57\" style=\"transform:translate3d(0,0,0);\"><p><strong>Method for minimal residual disease detection in cancer patients<\/strong><\/p>\n<div class=\"fusion-text fusion-text-57\" style=\"transform:translate3d(0,0,0);\"><\/div>\n<p><strong>Group:<\/strong> : Research Group of Innovative Diagnostic and Therapeutical Developments in Solid Tumors<\/p>\n<\/div><div class=\"fusion-text fusion-text-59\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type:<\/strong> Patent<\/p>\n<\/div><div class=\"fusion-text fusion-text-60\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/05\/i2025_01_Technological-offer_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Descripci\u00f3n<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-14{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-14 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-14{width:50% !important;order : 0;}.fusion-builder-nested-column-14 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-14{width:100% !important;order : 0;}.fusion-builder-nested-column-14 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-15 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\">\n<div class=\"fusion-text fusion-text-61\" style=\"transform:translate3d(0,0,0);\"><p><strong>Nanoparticles-based therapy for ischemic cardiopathies<\/strong><\/p>\n<div class=\"fusion-text fusion-text-61\" style=\"transform:translate3d(0,0,0);\"><\/div>\n<p><strong>Grupo:<\/strong> Grupo de Investigaci\u00f3n Traslacional en Cardiopat\u00eda Isqu\u00e9mica<\/p>\n<\/div><div class=\"fusion-text fusion-text-63\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type:<\/strong> Patent<\/p>\n<\/div><div class=\"fusion-text fusion-text-64\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/09\/Technology-offer_i2024_36_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-15{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-15 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-15{width:50% !important;order : 0;}.fusion-builder-nested-column-15 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-15{width:100% !important;order : 0;}.fusion-builder-nested-column-15 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-16 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\">\n<div class=\"fusion-text fusion-text-65\" style=\"transform:translate3d(0,0,0);\"><p><strong>Microbiological Information Bulletin(BIMIC)<\/strong><\/p>\n<div class=\"fusion-text fusion-text-65\" style=\"transform:translate3d(0,0,0);\"><\/div>\n<p><strong>Group:<\/strong> Grupo de Investigaci\u00f3n en Microbiolog\u00eda Molecular y Patog\u00e9nesis Microbiana<\/p>\n<\/div><div class=\"fusion-text fusion-text-67\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type: <\/strong>Software<\/p>\n<\/div><div class=\"fusion-text fusion-text-68\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/10\/i2024_31_Technological-offer_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-16{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-16 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-16{width:50% !important;order : 0;}.fusion-builder-nested-column-16 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-16{width:100% !important;order : 0;}.fusion-builder-nested-column-16 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-17 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\">\n<div class=\"fusion-text fusion-text-69\" style=\"transform:translate3d(0,0,0);\"><p><strong>i2024\/30 EndosCitas y EndosNet<\/strong><\/p>\n<div class=\"fusion-text fusion-text-69\" style=\"transform:translate3d(0,0,0);\"><\/div>\n<p><strong>Grupo:<\/strong> Servicio de Medicina Digestiva \/ Unidad de endoscopias<\/p>\n<\/div><div class=\"fusion-text fusion-text-71\" style=\"transform:translate3d(0,0,0);\"><p><strong>Tipo: <\/strong>Software<\/p>\n<\/div><div class=\"fusion-text fusion-text-72\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/11\/Oferta-Tecnologica_i2024_30.pdf\" target=\"_blank\" rel=\"noopener\">Descripci\u00f3n<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-17{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-17 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-17{width:50% !important;order : 0;}.fusion-builder-nested-column-17 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-17{width:100% !important;order : 0;}.fusion-builder-nested-column-17 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-18 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\">\n<div class=\"fusion-text fusion-text-73\" style=\"transform:translate3d(0,0,0);\"><p><strong>Angiopath<\/strong><\/p>\n<div class=\"fusion-text fusion-text-73\" style=\"transform:translate3d(0,0,0);\"><\/div>\n<p><strong>Grupo:<\/strong> Grupo de Investigaci\u00f3n Translacional de Tumores S\u00f3lidos Pedi\u00e1tricos<\/p>\n<\/div><div class=\"fusion-text fusion-text-75\" style=\"transform:translate3d(0,0,0);\"><p><strong>Tipo: <\/strong>Software<\/p>\n<\/div><div class=\"fusion-text fusion-text-76\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/11\/F-UAI-Tran-1_Angiopath_ES.pdf\" target=\"_blank\" rel=\"noopener\">Descripci\u00f3n<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-18{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-18 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-18{width:50% !important;order : 0;}.fusion-builder-nested-column-18 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-18{width:100% !important;order : 0;}.fusion-builder-nested-column-18 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-19 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-77\" style=\"transform:translate3d(0,0,0);\"><p><strong>HISTSHOCK IVD: A diagnostic and Decision-Support Software for Sepsis and Septic Shock Management<\/strong><\/p>\n<div class=\"fusion-text fusion-text-77\" style=\"transform:translate3d(0,0,0);\"><\/div>\n<p><strong>Group:<\/strong> Epigen\u00f3mica y Epigen\u00e9tica traslacional<\/p>\n<\/div><div class=\"fusion-text fusion-text-79\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type: <\/strong>Software<\/p>\n<\/div><div class=\"fusion-text fusion-text-80\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2026\/01\/251110_Oferta-tecnologica__i2025_19_Histshock_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-19{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-19 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-19{width:50% !important;order : 0;}.fusion-builder-nested-column-19 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-19{width:100% !important;order : 0;}.fusion-builder-nested-column-19 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-20 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-81\" style=\"transform:translate3d(0,0,0);\"><p><strong>Algorithmic methodology for opportunistic detection and monitoring of chronic kidney disease<\/strong><\/p>\n<p><div class=\"fusion-text fusion-text-81\" style=\"transform:translate3d(0,0,0);\"><\/div>\n<strong>Group:<\/strong> Renal Disease Group<\/p>\n<\/div><div class=\"fusion-text fusion-text-83\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type: <\/strong>Know-how<\/p>\n<\/div><div class=\"fusion-text fusion-text-84\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2026\/02\/i2024_17_Technological-offer_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-20{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-20 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-20{width:50% !important;order : 0;}.fusion-builder-nested-column-20 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-20{width:100% !important;order : 0;}.fusion-builder-nested-column-20 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<\/div>\n<h2><\/h2>\n<h2>Spin-Off technology-based companies:<\/h2>\n<div ><span class=\" fusion-imageframe imageframe-none imageframe-1 hover-type-none\" style=\"margin-top:20px;margin-bottom:20px;\"><a class=\"fusion-no-lightbox\" href=\"https:\/\/www.seqplexing.com\/\" target=\"_blank\" aria-label=\"Seqplexing\" rel=\"noopener noreferrer\"><img width=\"200\" height=\"66\" src=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/Seqplexing-200x66.jpg\" class=\"img-responsive wp-image-8218\" srcset=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/Seqplexing-200x66.jpg 200w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/Seqplexing-400x132.jpg 400w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/Seqplexing-600x198.jpg 600w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/Seqplexing.jpg 744w\" sizes=\"(max-width: 640px) 100vw, 200px\" \/><\/a><\/span><\/div>\n<p><strong>Seqplexing<\/strong> is a company created in 2013, which was born from the idea of generating solutions for research and clinical applications, using as a basis the introduction of new advanced genetic techniques and platforms, mainly next generation sequencing (NGS). Seqplexing aims to cover the need for reliable protocols for the sequencing of amplicons or genes. To this end, it develops closed solutions that are easy to use and implement in its own laboratories.<\/p>\n<p>Seqplexing&#8217;s mission is focused on providing a service to those laboratories that, due to their daily routine, do not have time to carry out the development of suitable protocols for the sequencing of genes or regions of interest. Seqplexing is transforming into a commercial kit all the necessary elements to carry out these techniques, providing a comprehensive service from the beginning of the sample preparation to the final analysis of the results.<\/p>\n<div ><span class=\" fusion-imageframe imageframe-none imageframe-2 hover-type-none\" style=\"margin-top:20px;margin-bottom:20px;\"><a class=\"fusion-no-lightbox\" href=\"http:\/\/www.epidisease.com\/\" target=\"_blank\" aria-label=\"Epidisease Logo Carnet\" rel=\"noopener noreferrer\"><img width=\"437\" height=\"142\" src=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/Epidisease-Logo-Carnet.jpg\" class=\"img-responsive wp-image-8216\" srcset=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/Epidisease-Logo-Carnet-200x65.jpg 200w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/Epidisease-Logo-Carnet-400x130.jpg 400w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/Epidisease-Logo-Carnet.jpg 437w\" sizes=\"(max-width: 640px) 100vw, 437px\" \/><\/a><\/span><\/div>\n<p><strong>Epidisease<\/strong> was created in 2014 because of a project led by INCLIVA researchers and the Center for Biomedical Research Network (CIBER) of Rare Diseases to transfer knowledge in the field of epigenetics and biomedical sciences to the service of society.<\/p>\n<p>Epigenetics studies all those factors and mechanisms involved in the control of gene expression. The importance of this science is growing, as demonstrated by some of the conclusions of the Human Genome Project, thanks to which scientist have realised that the molecular bases of cellular functioning, development, ageing and many diseases goes far beyond the DNA sequence. Proof of this are recent findings from the Epigenome Road Map project.<\/p>\n<p>Epidiseases\u2019s mission is to leverage its expensive expertise in the field of epigenetics to provide its customers with biomedical solutions, diagnostic tools and new therapies, as well as to stimulate translational research with the goal of improving people\u2019s health and well-being.<\/p>\n<div ><span class=\" fusion-imageframe imageframe-none imageframe-3 hover-type-none\" style=\"margin-top:20px;margin-bottom:20px;\"><a class=\"fusion-no-lightbox\" href=\"http:\/\/www.nelabiodynamics.com\/\" target=\"_blank\" aria-label=\"LOGO_nela\" rel=\"noopener noreferrer\"><img width=\"500\" height=\"121\" src=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/LOGO_nela.png\" class=\"img-responsive wp-image-8217\" srcset=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/LOGO_nela-200x48.png 200w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/LOGO_nela-400x97.png 400w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/LOGO_nela.png 500w\" sizes=\"(max-width: 640px) 100vw, 500px\" \/><\/a><\/span><\/div>\n<p><strong>Nela BioDynamics <\/strong>is a young technology development company in biomedicine, which arises from Valencian university collaboration, formed by a group of multidisciplinary researchers with expertise in biomedicine and engineering. The company arises from the results of a master&#8217;s Thesis in Biomedical Engineering, which led to the obtaining of two patents on a novel intramedullary fixation device for joint arthroplasty, nails for fractures and exo-prosthetization; and a percutaneous collar for ostomies.<\/p>\n<p>NELA spinal implant technology allows for a customised fit for each patient and avoids conventional techniques based on impact pressure fitting or the use of bone cement to achieve fixation. All this translates into a shorter surgical time, less pain, higher success rates and better quality of life for the patient. NELAS\u2019s mission is to respond to different unmet medical need, while providing a positive socio-economic impact.<\/p>\n<div ><span class=\" fusion-imageframe imageframe-none imageframe-4 hover-type-none\" style=\"margin-top:20px;margin-bottom:20px;\"><a class=\"fusion-no-lightbox\" href=\"https:\/\/arthexbiotech.com\/\" target=\"_blank\" aria-label=\"1605864958807\" rel=\"noopener noreferrer\"><img width=\"750\" height=\"249\" src=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/1605864958807.jpg\" class=\"img-responsive wp-image-8215\" srcset=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/1605864958807-200x66.jpg 200w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/1605864958807-400x133.jpg 400w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/1605864958807-600x199.jpg 600w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/1605864958807.jpg 750w\" sizes=\"(max-width: 640px) 100vw, 750px\" \/><\/a><\/span><\/div>\n<p><strong>ARTHEx BIOTECH <\/strong>is a spin-off company of the University of Valencia that develops advanced RNA treatments against genetic diseases. The team has a solid experience in drug discovery and the involvement of microRNAs in neuromuscular diseases. They are supported by world-renowned scientific and clinical advisors who will facilitate the successful development of their products.<\/p>\n<p>ARTHEx Biotech mission is to find effective treatments for unmet medical needs. The company\u2019s first objective will be to investigate anti-miRNAs for the treatment of myotonic dystrophy type 1 (DM1), which is an orphan disease affecting more than 900 000 people worldwide (estimated prevalence 1\/8000).<\/p>\n<ul>\n<li><a href=\"\/wp-content\/uploads\/2025\/05\/Politica-de-la-innovacion-20250331.pdf\">Innovation policy<\/a><\/li>\n<li><a href=\"\/wp-content\/uploads\/2021\/documentacion\/innovacion\/Vision-y-Estrategia-de-IDi.pdf\">R&amp;D&amp;I vision and strategy<\/a><\/li>\n<li><a href=\"\/wp-content\/uploads\/2021\/documentacion\/innovacion\/Directices de Innovaci\u00f3n INCLIVA 2019.pdf\">Innovation guidelines<\/a><\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-0{width:100% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-0 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 1.92%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-column-0{width:100% !important;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-0{width:100% !important;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><\/div><style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-1{ padding-top : 0px;margin-top : 0px;padding-right : 0px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 0px;}<\/style><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#e2e2e2;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_1_1 1_1 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-1{width:100% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-1 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 1.92%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-column-1{width:100% !important;}.fusion-builder-column-1 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-1{width:100% !important;}.fusion-builder-column-1 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><\/div><style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-2{ padding-top : 0px;margin-top : 0px;padding-right : 0px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 0px;}<\/style><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":13,"featured_media":0,"parent":10472,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/pages\/46275"}],"collection":[{"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/comments?post=46275"}],"version-history":[{"count":6,"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/pages\/46275\/revisions"}],"predecessor-version":[{"id":49710,"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/pages\/46275\/revisions\/49710"}],"up":[{"embeddable":true,"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/pages\/10472"}],"wp:attachment":[{"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/media?parent=46275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}